Literature DB >> 10338532

Analysis of vaginal cell populations during experimental vaginal candidiasis.

P L Fidel1, W Luo, C Steele, J Chabain, M Baker, F Wormley.   

Abstract

Studies with an estrogen-dependent murine model of vaginal candidiasis suggest that local cell-mediated immunity (CMI) is more important than systemic CMI for protection against vaginitis. The present study, however, showed that, compared to uninfected mice, little to no change in the percentage or types of vaginal T cells occurred during a primary vaginal infection or during a secondary vaginal infection where partial protection was observed. Furthermore, depletion of polymorphonuclear leukocytes (PMN) had no effect on infection in the presence or absence of pseudoestrus. These results indicate a lack of demonstrable effects by systemic CMI or PMN against vaginitis and suggest that if local T cells are important, they are functioning without showing significant increases in numbers within the vaginal mucosa during infection.

Entities:  

Mesh:

Year:  1999        PMID: 10338532      PMCID: PMC96633          DOI: 10.1128/IAI.67.6.3135-3140.1999

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

1.  Acute neutropenia decreases inflammation associated with murine vaginal candidiasis but has no effect on the course of infection.

Authors:  C A Black; F M Eyers; A Russell; M L Dunkley; R L Clancy; K W Beagley
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

2.  Vaginal-associated immunity in women with recurrent vulvovaginal candidiasis: evidence for vaginal Th1-type responses following intravaginal challenge with Candida antigen.

Authors:  P L Fidel; K A Ginsburg; J L Cutright; N A Wolf; D Leaman; K Dunlap; J D Sobel
Journal:  J Infect Dis       Date:  1997-09       Impact factor: 5.226

3.  Cyclic variations in white cell subpopulations in the human menstrual cycle: correlations with progesterone and estradiol.

Authors:  S Mathur; R S Mathur; J M Goust; H O Williamson; H H Fudenberg
Journal:  Clin Immunol Immunopathol       Date:  1979-07

4.  Immunity to Candida albicans.

Authors:  T J Rogers; E Balish
Journal:  Microbiol Rev       Date:  1980-12

Review 5.  Protective immunity against HSV-2 in the mouse vagina.

Authors:  M B Parr; E L Parr
Journal:  J Reprod Immunol       Date:  1997-11-30       Impact factor: 4.054

6.  Mucosal immunity to herpes simplex virus type 2 infection in the mouse vagina is impaired by in vivo depletion of T lymphocytes.

Authors:  M B Parr; E L Parr
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

7.  Fungicidal activity of murine inflammatory polymorphonuclear neutrophils: comparison with murine peripheral blood PMN.

Authors:  E Brummer; J G McEwen; D A Stevens
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

8.  [Weakness of cellular response to Listeria antigens in pregnant mice].

Authors:  M Klink; B Rózalska; W Rudnicka
Journal:  Med Dosw Mikrobiol       Date:  1993

9.  Participation of C3 in intracellular killing of Candida albicans.

Authors:  M Yamamura; H Valdimarsson
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

10.  Physiologic regulation of postovulatory neutrophil migration into vagina in mice by a C-X-C chemokine(s).

Authors:  Y Sonoda; N Mukaida; J B Wang; M Shimada-Hiratsuka; M Naito; T Kasahara; A Harada; M Inoue; K Matsushima
Journal:  J Immunol       Date:  1998-06-15       Impact factor: 5.422

View more
  38 in total

1.  Deletion of the two-component histidine kinase gene (CHK1) of Candida albicans contributes to enhanced growth inhibition and killing by human neutrophils in vitro.

Authors:  Antonella Torosantucci; Paola Chiani; Flavia De Bernardis; Antonio Cassone; Jose Antonio Calera; Richard Calderone
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

2.  Cell adhesion molecule and lymphocyte activation marker expression during experimental vaginal candidiasis.

Authors:  F L Wormley; J Chaiban; P L Fidel
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  Effects of reproductive hormones on experimental vaginal candidiasis.

Authors:  P L Fidel; J Cutright; C Steele
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

4.  Phenotypic and functional characterization of vaginal dendritic cells in a rat model of Candida albicans vaginitis.

Authors:  Flavia De Bernardis; Roberta Lucciarini; Maria Boccanera; Consuelo Amantini; Silvia Arancia; Stefania Morrone; Michela Mosca; Antonio Cassone; Giorgio Santoni
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 5.  Anticandidal immunity and vaginitis: novel opportunities for immune intervention.

Authors:  Antonio Cassone; Flavia De Bernardis; Giorgio Santoni
Journal:  Infect Immun       Date:  2007-06-11       Impact factor: 3.441

6.  Protocols for vaginal inoculation and sample collection in the experimental mouse model of Candida vaginitis.

Authors:  Junko Yano; Paul L Fidel
Journal:  J Vis Exp       Date:  2011-12-08       Impact factor: 1.355

7.  Local production of chemokines during experimental vaginal candidiasis.

Authors:  M Saavedra; B Taylor; N Lukacs; P L Fidel
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

Review 8.  Cytokines in the host response to Candida vaginitis: Identifying a role for non-classical immune mediators, S100 alarmins.

Authors:  Junko Yano; Mairi C Noverr; Paul L Fidel
Journal:  Cytokine       Date:  2011-12-17       Impact factor: 3.861

9.  Candida-specific antibodies during experimental vaginal candidiasis in mice.

Authors:  Karen L Wozniak; Floyd L Wormley; Paul L Fidel
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

10.  An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopathogenesis of vulvovaginal candidiasis.

Authors:  Paul L Fidel; Melissa Barousse; Terri Espinosa; Mercedes Ficarra; Joy Sturtevant; David H Martin; Alison J Quayle; Kathleen Dunlap
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.